The Lancet Respiratory Medicine published a phase 2 clinical study article on China's first DPP-1 inhibitor, HSK31858, led by ...

Background: Pulmonary mucosa-associated lymphoid tissue (MALT) lymphoma is a rare, indolent subtype of non-Hodgkin lymphoma ...

Pulmonologists share best practices on when primary care providers should consider sending patients with respiratory ...

These guidelines aimed to improve the standard of care and management of bronchiectasis based on the treatable causes and pathophysiology of the disease. Thus, current guidelines in bronchiectasis ...

Bronchiectasis patients are at higher risk of acquiring CAP due to underlying pathophysiology of bronchiectasis. Vaccination is therefore recommended in bronchiectasis guidelines irrespective of age.

You can remove mucus from the lungs using natural remedies, controlled coughing, and chest physical therapy. If these natural techniques don't help, you may need over-the-counter or prescription ...

The FDA has started a priority review of Insmed's brensocatib, which is pitching to become the first approved therapy for chronic lung disease bronchiectasis in the US. The regulator has set a ...